
Psychedelic Therapy in Pennsylvania: Philadelphia, Pittsburgh & Legal Access
Psychedelic therapy in Pennsylvania is at an early but real stage of development. Ketamine is the only legally available psychedelic-assisted treatment within the state right now,...

Psilocybin for End-of-Life Anxiety: What the Research Shows
Research into psilocybin for end-of-life anxiety has produced some of the most compelling clinical data in psychedelic science. Landmark trials at Johns Hopkins and NYU found...

Psychedelic Therapy Contraindications: Who Should Pause First
Psychedelic therapy contraindications include a personal history of psychosis or mania, current lithium use, certain cardiac conditions, and active suicidal ideation with intent. Some of these...

What Happens in a Psychedelic Therapy Session: A Full Walk-Through
A professionally supported psychedelic experience is a structured, clinically informed process that unfolds across several weeks. Understanding what happens in a psychedelic therapy session requires looking...

Ibogaine Opioid Treatment Research: What 2025-2026 Studies Found
Ibogaine opioid treatment research has moved significantly forward in 2025 and 2026, with new clinical data, a landmark $50 million Texas state investment, and a federal...

Executive Burnout Psychedelic Therapy: What the Research Shows
Executive burnout psychedelic therapy is moving from the research margins into serious clinical conversation. A growing body of peer-reviewed evidence suggests that psilocybin-assisted therapy can reduce...

Ayahuasca Therapy Guide: What to Know Before You Go
This ayahuasca therapy guide covers what you need to know before considering a ceremony or retreat: how it works pharmacologically, what the safety risks actually are,...

Psychedelics and Creativity: What Executives Need to Know
Interest in psychedelics and creativity among executives has moved well beyond Silicon Valley. Neuroscientific research points to measurable changes in divergent thinking, cognitive flexibility, and problem-solving...

Psychedelic Therapy Privacy: What Executives Need to Know
Psychedelic therapy privacy is one of the most legitimate concerns executives and public figures raise before pursuing treatment. HIPAA protections apply to licensed clinical providers, and...

Set and Setting in 2026: A Psychedelic Preparation Guide for High-Performers
Set and setting psychedelics research refers to the two core non-pharmacological factors that shape a psilocybin experience: your internal state (set) and the physical and relational...
Ready to take the next step?
Start with a complimentary conversation, or take the two-minute self-evaluation to see if this is your moment.